This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

18 Nov 2013

Almac Further Enhances 3rd Party Logistics Commercial Support Services for Niche/Orphan Drugs

Almac, a leading provider of contract services to the global pharmaceutical and biotech industries, announces the release of an enhanced 3rd Party Logistics (3PL) Customer Billing Application.


In response to growing client demand for fully integrated end to end support of EU product launches, from import testing, country-specific packaging, QP release, online ordering, direct to pharmacy distribution and financial services, Almac has enhanced their customer billing software to facilitate a seamless invoicing process on behalf of 3PL clients.


3PL orders, received directly from hospitals/clinics/pharmacies, for niche/orphan drug products, will now be processed, dispatched, and automatically invoiced on the client’s behalf. The process will be completed by reconciliation of payments to the client’s EU account, as well as debtor follow up.


David Downey, VP Commercial Operations of Almac explains: “With our client partners, we have successfully launched many high-value, orphan drug/niche products into the European market. With this enhancement to our customer billing application, we can alleviate the client’s administrative burden, by essentially becoming an extension of their supply chain team and assist in managing cash receipts and debtor follow up. Particularly for US-based clients with no EU operational footprint, this end to end service provides a compelling business case to partner with an experienced EU solutions provider.”


Related News